Trials / Completed
CompletedNCT01355172
Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old
Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011， in Infants Aged Between 6-12months Old
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Adimmune Corporation · Industry
- Sex
- All
- Age
- 6 Months – 1 Year
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the antibody response to each of the three influenza vaccine strains included in the seasonal flu vaccine(AdimFlu-S), as measured by hemagglutination inhibition (HAI) at 4 weeks after two doses of study vaccine, 4 weeks apart, in infants between 6 and 12 months of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AdimFlu-S | 0.25mL per injection 2 injections at 4 weeks apart |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-09-01
- First posted
- 2011-05-18
- Last updated
- 2012-07-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01355172. Inclusion in this directory is not an endorsement.